Hequan Pharmaceutical Shanghai Clinical Supply Chain Service Center was officially opened to accelerate the supply of clinical drugs

Hequan Pharmaceutical Shanghai Clinical Supply Chain Service Center

Hequan Pharmaceutical, a subsidiary of WuXi AppTec, recently announced that the clinical supply chain service center in Waigaoqiao, Shanghai was officially opened to provide partners with one-stop clinical drug supply chain services, helping The efficient implementation of clinical trials will promote the early launch of candidate new drugs.

Hequan Pharmaceutical Shanghai Clinical Supply Chain Service Center is located in its integrated base of APIs and preparations in Shanghai Waigaoqiao Free Trade Zone, which can support Phase 1-4 clinical studies. The clinical supply center has storage capacity and comprehensive packaging capacity under various temperature control conditions, focusing on providing partners with reference drug procurement, primary/secondary packaging design, label design and printing, labeling, warehousing and distribution, refrigeration Comprehensive, end-to-end services such as chain transportation, experimental drug recovery and destruction to meet the growing and diverse clinical trial needs of our partners.

Clinical trials are the most critical link in the development of new drugs, and the clinical supply chain is a complex system process involving multiple parties. Relying on the integrated empowerment platform of Hequan Pharmaceutical, the R&D, production and other teams work in parallel, and the seamless collaboration between the CMC project management and the clinical supply project management team, so that the clinical supply chain service of Hequan Pharmaceutical can be significantly shortened from R&D to clinical time. At the same time, Hequan Pharmaceutical has a quality system that meets international standards, providing a solid quality assurance for supporting partners’ global clinical research.

As an industry-leading contract research, development and manufacturing company (CRDMO) for new drugs, Hequan Pharmaceutical has 12 R&D and manufacturing bases around the world, located in Asia, North America and Europe. , Shanghai Waigaoqiao Clinical Supply Chain Service Center has further upgraded the CRDMO integrated service. In the future, Hequan Pharmaceutical’s clinical supply network will continue to be upgraded and expanded to better meet the needs of customers for global clinical trials.

Dr. Chen Minzhang, Co-CEO of WuXi AppTec and CEO of Hequan Pharmaceutical, said: “Hequan Pharmaceutical always pays attention to customer needs. With the official opening of the Shanghai Clinical Supply Chain Service Center, , we will better empower partners through the CRDMO platform. The company’s integrated platform and quality system that meets international standards allow us to provide industry-leading efficiency, production capacity, quality and flexibility, helping partners accelerate from R&D to The clinical speed will further accelerate the development of new drugs, so that innovative drugs can benefit patients as soon as possible.”

About Hequan Pharmaceutical

United Pharma is a subsidiary of WuXi AppTec with R&D and production bases in Asia, North America and Europe. Hequan Pharma serves the life science industry and has excellent capabilities and technology platforms for R&D and production of innovative chemical drugs. As a global leader in contract research, development and manufacturing of new drugs (CRDMO), Hequan Pharmaceutical is committed to providing global partners with efficient, flexible and high-quality one-stop solutions to support products including small molecules, oligonucleotides Research and development and production of acids, peptides and various complex chemical conjugated drugs. For more information, please visit the company’s website: www.stapharma.com.cn.

WuXi AppTec provides integrated, end-to-end new drug R&D and production services for the global biopharmaceutical industry, covering chemical drug R&D and production, biological research, preclinical testing and clinical trials R&D, cell and gene therapy R&D, testing and production. If you have relevant business needs, please click the picture below to fill in the specific information.